161909-27-9

Basic information

• Product Name: 1,3''-bis(N-benzyloxycarbonyl)-3,2',6'-tris(N-tert-butoxycarbonyl)dibekacin
• Synonyms: 1,3''-bis(N-benzyloxycarbonyl)-3,2',6'-tris(N-tert-butoxycarbonyl)dibekacin
• CAS NO: 161909-27-9
• Molecular Weight: 1020.14
• Mol File: 161909-27-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1,3''-bis(N-benzyloxycarbonyl)-3,2',6'-tris(N-tert-butoxycarbonyl)dibekacin(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3''-bis(N-benzyloxycarbonyl)-3,2',6'-tris(N-tert-butoxycarbonyl)dibekacin(161909-27-9)
• EPA Substance Registry System: 1,3''-bis(N-benzyloxycarbonyl)-3,2',6'-tris(N-tert-butoxycarbonyl)dibekacin(161909-27-9)

Safety Data

• Hazardous Substances Data: 161909-27-9(Hazardous Substances Data)

Upstream product

• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 

Downstream Products

• 161906-84-9 4'',6''-O-benzylidene-1,3''-bis(N-benzyloxycarbonyl)-3,2',6'-tris(N-tert-butoxycarbonyl)-2''-(tert-butoxycarbonyl)amino-2''-deoxydibekacin 
• 1055032-19-3 6''-O-benzoyl-1,3''-bis(N-benzyloxycarbonyl)-3,2',6'-tris(N-tert-butoxycarbonyl)-2''-(tert-butoxycarbonyl)amino-2''-deoxydibekacin 
• 161822-14-6 6''-O-benzoyl-1,3''-bis(N-benzyloxycarbonyl)-3,2',6'-tris(N-tert-butoxycarbonyl)-2''-(tert-butoxycarbonyl)amino-2'',4''-dideoxydibekacin 
• 161822-08-8 4'',6''-O-benzylidene-1,3''-bis(N-benzyloxycarbonyl)-3,2',6'-tris(N-tert-butoxycarbonyl)-2''-(tert-butoxycarbonyl)amino-5,2''-dideoxydibekacin 
• 161909-28-0 C₅₆H₇₅N₅O₁₈ 
• 161822-12-4 1,3''-bis(N-benzyloxycarbonyl)-3,2',6'-tris(N-tert-butoxycarbonyl)-2''-(tert-butoxycarbonyl)amino-2''-deoxydibekacin 
• 161972-20-9 2''-amino-4'',6''-O-benzylidene-1,3''-bis(N-benzyloxycarbonyl)-3,2',6'-tris(N-tert-butoxycarbonyl)-2''-deoxydibekacin 
• 1053258-65-3 1,3''-bis(N-benzyloxycarbonyl)-3,2',6'-tris(N-tert-butoxycarbonyl)-2''-(tert-butoxycarbonyl)amino-2'',4''-dideoxydibekacin 
• 161822-16-8 3''-(N-benzyloxycarbonyl)-3,2',6'-tris(N-tert-butoxycarbonyl)-2''-(tert-butoxycarbonyl)amino-2'',4''-dideoxydibekacin 
• 161906-85-0 4'',6''-O-benzylidene-3,2',6'-tris(N-tert-butoxycarbonyl)-2''-(tert-butoxycarbonyl)amino-2''-deoxydibekacin 
• 161906-86-1 4'',6''-O-benzylidene-3,2',6'-tris(N-tert-butoxycarbonyl)-2''-(tert-butoxycarbonyl)amino-5,2''-dideoxydibekacin 
• 147920-22-7 2''-amino-2''-deoxyarbekacin 
• 161822-13-5 6''-O-benzoyl-1,3''-bis(N-benzyloxycarbonyl)-3,2',6'-tris(N-tert-butoxycarbonyl)-2''-(tert-butoxycarbonyl)amino-2''-deoxy-4''-O-mesyldibekacin 
• 161822-07-7 4'',6''-O-benzylidene-1,3''-bis(N-benzyloxycarbonyl)-3,2',6'-tris(N-tert-butoxycarbonyl)-2''-(tert-butoxycarbonyl)amino-2''-deoxy-5-O-(methylthio)-thiocarbonyldibekacin 

Relevant articles and documents

Synthesis of 2'-amino-2'-deoxyarbekacin and its analogs having potent activity against methicillin-resistant Staphylococcus aureus

Based on our studies on the enzymatic modifications of arbekacin by methicillin-resistant Staphylococcus aureus (MRSA), replacement of the 2'-hydroxyl group by an amino group in arbekacin was designed to synthesize derivatives that would be active against